StockTipsArenaBeta

BUY Artemis Medicare Services Limited — Kush Bohra

BUYArtemis Medicare Services Limited
Artemis Medicare Services share price target & all analyst calls

byKush BohraHorizon: NA (inferred Intraday)5 Aug 2026, 1:42 pm ISTvia NDTV Profit

Entry₹321.55Inferred
Target₹325
Total upside +1.07% (call closed)
Stop lossNot given
At expiry₹321.15 Aug 2026, 3:20 pm
Expired-0.14%
Follow Kush Bohra for new calls(17% target hit, 24 closed calls)Get alertsWatch ARTEMISMED for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 5 Aug 2026
2 supporting2 neutral0 opposing
Supports the BUY call (2)

Artemis Medicare Services Limited reported a 12.7% YoY increase in consolidated revenue for Q1 FY27, with EBITDA up 27.9% and profit up 48.3%.

NSE · Press Release·3 Aug · yesterday

(opens in new tab)

Artemis Medicare Services Ltd announced its Q1 FY27 financial results, showing a 12.7% YoY increase in consolidated revenue to Rs 28,732 Lacs. EBITDA grew by 27.9% to Rs 6,182 Lacs, and PAT increased

BSE · Company Update·3 Aug · yesterday

(opens in new tab)
Neutral / worth noting (2)

Artemis Medicare Services Limited announced its un-audited financial results for the quarter ended June 30, 2026, and an expansion plan for Tower IV at its flagship hospital in Gurugram.

NSE · Outcome of Board Meeting·3 Aug · yesterday

(opens in new tab)

Artemis Medicare Services Ltd announced the outcome of its Board Meeting held on August 3, 2026. The board approved the un-audited financial results for the quarter ended June 30, 2026, and an expansi

BSE · Board Meeting·3 Aug · yesterday

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Artemis Medicare Services

All analyst calls on Artemis Medicare Services

More from Kush Bohra

Every call and its outcome